Kevin Xie is a seasoned business development professional with a focus on pharmaceuticals. He currently serves as the Director of Business Development at Bayer Pharmaceuticals, a leading global healthcare company. With over a decade of experience in the industry, Kevin has developed expertise in deal structuring, licensing, strategic partnerships, and mergers and acquisitions.

Prior to his current role, Kevin worked at AstraZeneca, a multinational pharmaceutical company, where he held various leadership positions in business development and corporate strategy. He also served as a consultant at McKinsey & Company, where he advised clients on strategic and operational issues in the healthcare industry.

Kevin holds a Bachelor of Science in chemical engineering from the Massachusetts Institute of Technology (MIT) and an MBA from the Wharton School at the University of Pennsylvania. With his strong background in science, business and consulting, Kevin has a proven track record of identifying and executing high-impact strategic initiatives that drive growth and increase profitability.